Alternative Data for Petros Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 7,751 | Sign up | Sign up | Sign up |
| X Mentions | 3 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Petros Pharmaceuticals
Petros Pharmaceuticals, Inc. is dedicated to identifying, acquiring, developing and marketing therapies for men's health problems in the United States and internationally. The company is headquartered in New York, New York.
| Price | $0.01 |
| Target Price | Sign up |
| Volume | 79,300 |
| Market Cap | $2.1M |
| Year Range | $0.01 - $0.04 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 0 | 0 | 0 | -2.3M | -1.5M | |
| Q4 '24 | 730,000 | 260,000 | 460,000 | -9.3M | -8.4M | -25.619 |
| Q3 '24 | 1.6M | 290,000 | 1.3M | -2.2M | -1.3M | -13.250 |
| Q2 '24 | 1.4M | 330,000 | 1.1M | -660,000 | 210,000 | -9.250 |
| Q1 '24 | 1.4M | 330,000 | 1.1M | -8M | -1.3M | -1.690 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Petros Pharmaceuticals (PTPI) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions & customer reviews.
FAQ - Petros Pharmaceuticals
The Market Cap of Petros Pharmaceuticals is $2.1M.
Currently, the price of one share of Petros Pharmaceuticals stock is $0.01.
The PTPI stock price chart above provides a comprehensive visual representation of Petros Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Petros Pharmaceuticals shares. Our platform offers an up-to-date PTPI stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Petros Pharmaceuticals (PTPI) does not offer dividends to its shareholders. Investors interested in Petros Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Petros Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
